The Pharmacy and Poisons Board (PPB) of Kenya has urgently recalled a specific batch of Sure lubricated condoms following serious quality concerns.
The recall pertains to Batch Number 2405055, which failed crucial integrity tests, particularly the “freedom from holes (conductivity) test,” essential for ensuring the reliability of the contraceptives. PPB CEO Dr. Fred Siyoi announced the recall on December 11, mandating an immediate halt to the distribution, sale, and use of condoms from the affected batch. He urges all pharmaceutical outlets, healthcare facilities, and the broader public to return any remaining products to their nearest facilities or suppliers.
“The Pharmacy and Poisons Board draws public attention to the recall of the substandard sure-lubricated condoms dotted, Batch No. 2405055,” noted the statement signed by PPB CEO Dr Fred Siyoi.
This action is particularly critical given Kenya’s dependence on condoms as a fundamental method in the fight against HIV, AIDS, and other sexually transmitted infections (STIs). The country has an estimated annual demand for 424 million condoms; however, current usage levels among Kenyan males fall significantly short of the recommended figures. This disparity heightens the potential public health risks associated with the defective products.
The current recall echoes a similar incident from October 2019 when the Kenya Medical Supplies Authority (KEMSA) recalled condom batches 17DN754 and 17DN052 due to quality assurance failures. Those batches had expiry dates spanning December 2021 to December 2022, leading to concerns about the oversight and quality control of essential public health products.
“Please accord Lifeline Laboratories the necessary operation in order to successfully conclude the process,” KEMSA quality assurance manager Dr John Aduda stated.
Ensuring the integrity of essential protective measures like condoms is critical to public health and sustaining confidence in health initiatives as Kenya confronts a heightened prevalence of STIs.
